-+ 0.00%
-+ 0.00%
-+ 0.00%

Deutsche Bank Downgrades Oxford Biomedica to Hold, Cuts PT

MT Newswires·08/18/2026 08:36:03
Listen to the news
08:36 AM EDT, 08/18/2026 (MT Newswires) -- Deutsche Bank on Tuesday downgraded British gene and cell therapy company Oxford Biomedica (OXB.L) to hold from buy and reduced its price target to 5.95 pounds sterling from 8 pounds. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)